Sona Saira Ramasastry
Direktor/Vorstandsmitglied bei GLENMARK PHARMACEUTICALS LIMITED
Vermögen: 747 930 $ am 30.04.2024
Aktive Positionen von Sona Saira Ramasastry
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GLENMARK PHARMACEUTICALS LIMITED | Direktor/Vorstandsmitglied | 01.04.2019 | - |
| Independent Dir/Board Member | 01.04.2019 | - | |
| VIR BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 01.09.2019 | - |
| Independent Dir/Board Member | 01.09.2019 | - | |
| DAY ONE BIOPHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.03.2021 | - |
| Independent Dir/Board Member | 01.03.2021 | - | |
| MIRUM PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 02.06.2022 | - |
| Independent Dir/Board Member | 02.06.2022 | - | |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Direktor/Vorstandsmitglied | 12.04.2021 | - |
| European Prevention of Alzheimer's Dementia Consortium | Corporate Officer/Principal | - | - |
Elevian, Inc.
 Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA. | Direktor/Vorstandsmitglied | - | - |
Pain Therapeutics, Inc.
 Pain Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Pain Therapeutics, Inc. develops drugs. | Direktor/Vorstandsmitglied | - | - |
| Aspen Global Leadership Network | Corporate Officer/Principal | - | - |
| ░░░░ ░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ | ░░░░░░░░░░ | - |
Karriereverlauf von Sona Saira Ramasastry
Ehemalige bekannte Positionen von Sona Saira Ramasastry
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░░░ ░░░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Sona Saira Ramasastry
| Stanford University | Graduate Degree |
| University of Cambridge | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 17 |
| Indien | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Director/Board Member | 13 |
| Independent Dir/Board Member | 9 |
| Corporate Officer/Principal | 3 |
Sektoral
| Health Technology | 13 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 7 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| CASSAVA SCIENCES, INC. | Health Technology |
| GLENMARK PHARMACEUTICALS LIMITED | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| 9 METERS BIOPHARMA, INC. | Health Technology |
| MIRUM PHARMACEUTICALS, INC. | Health Technology |
| DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
American Liver Foundation
 American Liver Foundation Miscellaneous Commercial ServicesCommercial Services American Liver Foundation engages in facilitating, advocating and promoting education, support, and research for the prevention, treatment, and cure of liver disease. It educates patients, policymakers and the public and provides grants to early-career researchers to help find a cure for all liver diseases. The company was founded in 1976 and is headquartered in New York, NY. | Commercial Services |
| Wasserstein Perella & Co., Inc. | |
| Life Sciences Advisory LLC | |
| Aspen Global Leadership Network | |
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
Pain Therapeutics, Inc.
Pain Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Pain Therapeutics, Inc. develops drugs. | Health Technology |
Elevian, Inc.
Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA. | Health Technology |
| European Prevention of Alzheimer's Dementia Consortium | |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Sona Saira Ramasastry
- Erfahrung
